Market revenue in 2023 | USD 4.8 million |
Market revenue in 2030 | USD 10.5 million |
Growth rate | 12% (CAGR from 2023 to 2030) |
Largest segment | Epinephrine |
Fastest growing segment | Immunotherapies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antihistamines, Epinephrine, Immunotherapies, Other Drug Class |
Key market players worldwide | Nestle SA, Sanofi SA, DBV Technologies SA ADR, PureTech Health PLC, Regeneron Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd ADR, Protagonist Therapeutics Inc, Aravax, Alladapt Immunotherapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peanut allergy treatment market will help companies and investors design strategic landscapes.
Epinephrine was the largest segment with a revenue share of 47.92% in 2023. Horizon Databook has segmented the South Africa peanut allergy treatment market based on antihistamines, epinephrine, immunotherapies, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.
The peanut allergy treatment market in South Africa reflects a relatively lower prevalence of peanut allergies compared to some other regions. With a prevalence of 1.1%, peanut allergies affect a smaller portion of the population in this country. This lower prevalence directly impacts the size and dynamics of the treatment market.
In South Africa, the peanut allergy treatment market is comparatively smaller and less competitive than the regions with higher prevalence rates. There are fewer individuals seeking treatment for peanut allergies, resulting in a more specialized and limited market. Healthcare providers and pharmaceutical companies offering peanut allergy treatments are present, but to a lesser extent.
A key trend in South Africa, as in many other parts of the world, is the increasing awareness of peanut allergies. The prevalence is relatively low, but the understanding of the seriousness of peanut allergies is growing. This leads to a heightened demand for accurate diagnosis, treatment, and management options for individuals with peanut allergies.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa peanut allergy treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Africa peanut allergy treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account